Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing.
Calugareanu A, de Masson A, Battistella M, Michel L, Ram-Wolff C, Bouaziz JD, Peltier S, Bensussan A, Bagot M, Dobos G. Calugareanu A, et al. Among authors: bensussan a. J Invest Dermatol. 2023 Oct;143(10):2078-2082.e4. doi: 10.1016/j.jid.2022.07.037. Epub 2023 Apr 24. J Invest Dermatol. 2023. PMID: 37100194 No abstract available.
CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.
Ta VA, Battistella M, Zhao LP, Dobos G, Ram-Wolff C, Madelaine I, Bories JC, Tournilhac O, Rouanet J, Veyrat-Masson R, Bouaziz JD, Marie-Cardine A, Bagot M, Bensussan A, Moins-Teisserenc H, De Masson A. Ta VA, et al. Among authors: bensussan a. J Invest Dermatol. 2023 Jul;143(7):1329-1332.e3. doi: 10.1016/j.jid.2023.01.009. Epub 2023 Jan 28. J Invest Dermatol. 2023. PMID: 36716922 No abstract available.
Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas.
Giustiniani J, Ta VA, Belkhelouat S, Battistella M, Ouahbi D, Ram-Wolff C, Louveau B, Mourah S, Bagot M, Moins-Teisserenc H, Ortonne N, Bensussan A, De Masson A. Giustiniani J, et al. Among authors: bensussan a. J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00259-8. doi: 10.1016/j.jid.2024.03.019. Online ahead of print. J Invest Dermatol. 2024. PMID: 38555062 Free article. No abstract available.
CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G, Thonnart N, Bozonnat A, Ram-Wolff C, de Masson A, Bensussan A, Bagot M, Marie-Cardine A, Battistella M. Battesti G, et al. Among authors: bensussan a. Skin Health Dis. 2024 Jan 10;4(2):e334. doi: 10.1002/ski2.334. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577051 Free PMC article.
CD160 receptor in CLL: Current state and future avenues.
Oumeslakht L, Aziz AI, Bensussan A, Ben Mkaddem S. Oumeslakht L, et al. Among authors: bensussan a. Front Immunol. 2022 Nov 7;13:1028013. doi: 10.3389/fimmu.2022.1028013. eCollection 2022. Front Immunol. 2022. PMID: 36420268 Free PMC article. Review.
Fc receptors act as innate immune receptors during infection?
Laassili C, Ben El Hend F, Benzidane R, Oumeslakht L, Aziz AI, El Fatimy R, Bensussan A, Ben Mkaddem S. Laassili C, et al. Among authors: bensussan a. Front Immunol. 2023 Jul 26;14:1188497. doi: 10.3389/fimmu.2023.1188497. eCollection 2023. Front Immunol. 2023. PMID: 37564652 Free PMC article. Review.
382 results